Wessel L du Toit
Overview
Explore the profile of Wessel L du Toit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
21
Followers
0
Related Specialties
Related Specialties
Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
du Toit W, Kruger R, Gafane-Matemane L, Schutte A, Louw R, Mels C
Amino Acids
. 2024 Aug;
56(1):53.
PMID: 39207612
The exposure to modifiable risk factors at young ages have been linked to premature fatal and non-fatal cardiovascular and kidney outcomes. The use of urinary metabolomics has shown strong predictability...
2.
du Toit W, Kruger R, Gafane-Matemane L, Schutte A, Louw R, Mels C
Nutr Metab Cardiovasc Dis
. 2023 May;
33(8):1574-1582.
PMID: 37246075
Background And Aims: Risk factor exposure from young ages was shown to contribute to cardiovascular events - cardiac hypertrophy, which may be accompanied by an altered metabolism. To determine how...
3.
du Toit W, Kruger R, Gafane-Matemane L, Schutte A, Louw R, Mels C
Metabolomics
. 2023 Mar;
19(4):28.
PMID: 36988718
Introduction: Increased exposure to risk factors in the young and healthy contributes to arterial changes, which may be accompanied by an altered metabolism. Objectives: To increase our understanding of early...
4.
du Toit W, Kruger R, Gafane-Matemane L, Schutte A, Louw R, Mels C
J Hypertens
. 2022 Jul;
40(8):1545-1555.
PMID: 35788095
Aim: Risk factors contributes to a dysregulated metabolism and may ultimately increase the predisposition for cardiovascular disease (CVD) development. To increase our understanding of mechanistic pathways associated with CVD risk,...
5.
du Toit W, Schutte A, Gafane-Matemane L, Kruger R, Mels C
Blood Press
. 2020 Oct;
30(2):98-107.
PMID: 33084438
Purpose: Raised blood pressure, with the renin-angiotensin system (RAS) as a central regulatory component, is one of the most important contributors to early development of left ventricular hypertrophy. Factors such...
6.
du Toit W, Schutte A, Mels C
J Hum Hypertens
. 2019 Nov;
34(9):648-656.
PMID: 31712713
Mounting evidence supports the central role of oxidative stress and inflammation in obesity and the development of hypertension. However, most studies focusing on the non-enzymatic antioxidants, such as uric acid...